Results of the phase 2 study M12-999: Interferon-free regimen of ABT-450/R/ABT-267 + ABT-333 + ribavirin in liver transplant recipients with recurrent HCV genotype 1 infection

Authors
Category Primary study
JournalJournal of Hepatology
Year 2014
This article has no abstract
Epistemonikos ID: b1f88aae9c9de68490f5913f416130ba0e961ccc
First added on: Feb 06, 2025